| 000 | 01594 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514231016.0 | ||
| 264 | 0 | _c20051011 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a1096-6374 | ||
| 024 | 7 |
_a10.1016/j.ghir.2005.02.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiermasz, Nienke R | |
| 245 | 0 | 0 |
_aIntravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly. _h[electronic resource] |
| 260 |
_bGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _cJun 2005 |
||
| 300 |
_a200-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAcromegaly _xdiagnosis |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOctreotide _xadministration & dosage |
| 650 | 0 | 4 | _aPituitary Function Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPereira, Alberto M | |
| 700 | 1 | _aSmit, Jan W A | |
| 700 | 1 | _aRomijn, Johannes A | |
| 700 | 1 | _aRoelfsema, Ferdinand | |
| 773 | 0 |
_tGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _gvol. 15 _gno. 3 _gp. 200-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ghir.2005.02.007 _zAvailable from publisher's website |
| 999 |
_c15596373 _d15596373 |
||